×
About 19,460 results

ALLMedicine™ Ankylosing Spondylitis Center

Research & Reviews  7,913 results

Clinical characteristics of axial spondyloarthritis patients in China: results from Chi...
https://www.ncbi.nlm.nih.gov/pubmed/33938794
Clinical and Experimental Rheumatology; Su J, Wang R et. al.

May 3rd, 2021 - The objective of this study is to describe the clinical features of patients with axial spondyloarthritis (axial SpA) in the ChinaSpA registry. Patients with clinical diagnosis of ankylosing spondylitis (AS) or axial SpA were enrolled into the reg...

Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis ...
https://doi.org/10.1007/s10067-021-05713-8
Clinical Rheumatology; Merola JF, Dennis N et. al.

May 2nd, 2021 - To compare healthcare resource utilization and costs among patients with psoriasis, psoriatic arthritis (PsA), and a control group of patients without psoriasis and PsA in the USA. The IBM® MarketScan® Commercial Database was used to identify thre...

The Effect of Pulmonary Rehabilitation Program on Work Productivity and Clinical Parame...
https://doi.org/10.1111/ijcp.14279
International Journal of Clinical Practice; Akaltun MS, Altindag O et. al.

Apr 29th, 2021 - The objective of the present study was to investigate the effect of the Pulmonary Rehabilitation Program on work productivity, disease activity, functional status, quality of life, Respiratory Function Tests (RFTs), physical capacity,and depressio...

Psoriatic arthritis and physical activity: a systematic review.
https://doi.org/10.1007/s10067-021-05739-y 10.1016/j.rdc.2015.07.001 10.1002/acr.20363 10.1097/rhu.0000000000000721 10.3899/jrheum.140021 10.5152/eurjrheum.2017 10.1002/acr.22926 10.1155/2012/714321 10.1016/j.jbspin.2019.12.004 10.1136/annrheumdis-2015-208466 10.1136/annrheumdis-2014-205675 10.1136/annrheumdis-2018-213585 10.1016/j.apmr.2017.07.015 10.1002/art.39573 10.1002/acr.23614 10.1136/rmdopen-2018-000729 10.1007/s00296-014-3141-9 10.2165/00007256-200838110-00003 10.1002/acr.21780 10.1016/j.hkpj.2015.10.001 10.3899/jrheum.180782 10.1007/s10067-017-3917-x 10.3109/03009749409103722 10.1016/j.semarthrit 10.1016/j.jbspin.2015.07.017 10.1016/j.atherosclerosis.2018.03.004 10.1111/echo.14103 10.1136/heartjnl-2015-307838 10.1136/annrheumdis-2013-203291 10.1007/s00296-018-4183-1 10.1111/joim.12715 10.1007/s10067-016-3304-z 10.1136/rmdopen-2017-000486 10.1589/jpts.28.2005 10.1136/annrheumdis-2013-203643 10.1007/s10067-013-2436-7 10.3899/jrheum.160715 10.3899/jrheum.190540 10.1007/s10067-014-2791-z 10.1111/jocn.12353 10.3109/09638281003649946 10.1093/rheumatology/ken380 10.1111/jocn.14606 10.1016/j.semarthrit.2019.10.002 10.1093/rheumatology/ken410 10.3899/jrheum.151244 10.3899/jrheum.080375 10.1016/s0196-0644(96)70238-x 10.1001/archdermatol.2012.943 10.1111/jdv.12607 10.1111/bjd.12735 10.1111/bjd.17741 10.1002/acr.24121 10.1136/annrheumdis-2017-212004 10.1002/art.39458 10.1007/s40744-021-00298-9
Clinical Rheumatology; Kessler J, Chouk M et. al.

Apr 29th, 2021 - The positive effects of physical activity in both rheumatoid arthritis and ankylosing spondylitis have been proven, but no clear data is yet published regarding psoriatic arthritis (PsA). The aims of this study were (i) to assess the level of phys...

see more →

Guidelines  37 results

2019 Update of the American College of Rheumatology/ Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis ...
https://www.rheumatology.org/Portals/0/Files/AxialSpA-Guideline-2019.pdf
Ward MM,et al

Sep 30th, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). ankylosing spondylitis

2019 Update of the American College of Rheumatology/Spondylitis Association of America/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764882
Arthritis & Rheumatology (Hoboken, N.J.); Ward MM, Deodhar A et. al.

Aug 22nd, 2019 - To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). We conducted updated systematic literature reviews for 20 clinical questions on pharmacologi...

FDA Approves Samsung Bioepis' HADLIMA™ (adalimumab-bwwd)
https://www.businesswire.com/news/home/20190723006033/en/FDA-Approves-Samsung-Bioepis-HADLIMA%E2%84%A2-adalimumab-bwwd

Jul 23rd, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved HADLIMA™ (adalimumab-bwwd), a biosimilar referencing HUMIRA® i (adalimumab), for the treatment of rheumatoid arthritis, juvenile idiopathic arthr...

FDA Approves ETICOVO™ (etanercept-ykro), Samsung Bioepis' Second Anti-TNF Medicine in the United States
http://www.samsungbioepis.com/en/newsroom/detail/FDA-Approves-ETICOVO-Samsung-Bioepis-Second-Anti-TNF-Medicine.html

Apr 28th, 2019 - Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved ETICOVO™ (etanercept-ykro), a biosimilar referencing ENBREL® (etanercept), across all eligible indications for the treatment of rheumatoid arthri...

2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guidelin...
https://www.rheumatology.org/Portals/0/Files/ACR-AAHKS-Perioperative-Management-Guideline.pdf
Goodman, S.,et al

Jul 31st, 2017 - This collaboration between the American College of Rheumatology and the American Association of Hip and Knee Surgeons developed an evidence-based guideline for the perioperative management of antirheumatic drug therapy for adults with rheumatoid a.

see more →

Drugs  1,139 results see all →

Clinicaltrials.gov  9,549 results

Clinical characteristics of axial spondyloarthritis patients in China: results from Chi...
https://www.ncbi.nlm.nih.gov/pubmed/33938794
Clinical and Experimental Rheumatology; Su J, Wang R et. al.

May 3rd, 2021 - The objective of this study is to describe the clinical features of patients with axial spondyloarthritis (axial SpA) in the ChinaSpA registry. Patients with clinical diagnosis of ankylosing spondylitis (AS) or axial SpA were enrolled into the reg...

Healthcare utilization and costs among patients with psoriasis and psoriatic arthritis ...
https://doi.org/10.1007/s10067-021-05713-8
Clinical Rheumatology; Merola JF, Dennis N et. al.

May 2nd, 2021 - To compare healthcare resource utilization and costs among patients with psoriasis, psoriatic arthritis (PsA), and a control group of patients without psoriasis and PsA in the USA. The IBM® MarketScan® Commercial Database was used to identify thre...

Diclofenac sodium delayed release - diclofenac sodium tablet, delayed release-NORTHWIND PHARMACEUTICALS
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c16e7e43-3869-9fef-e053-2995a90a1fdb

May 2nd, 2021 - Carefully consider the potential benefits and risks of diclofenac sodium delayed-release tablets and other treatment options before deciding to use diclofenac. Use the lowest effective dose for the shortest duration consistent with individual pati...

Naproxen - naproxen tablet-DIRECT RX
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b1b78c49-82e9-2402-e053-2a95a90ae35f

May 2nd, 2021 - CAREFULLY CONSIDER THE POTENTIAL BENEFITS AND RISKS OF NAPROXEN AND OTHER TREATMENT OPTIONS BEFORE DECIDING TO USE NAPROXEN TABLETS. USE THE LOWEST EFFECTIVE DOSE FOR THE SHORTEST DURATION CONSISTENT WITH INDIVIDUAL PATIENT TREATMENT GOALS (SEE WA...

see more →

News  771 results

Tofacitinib Effective for Ankylosing Spondylitis in Phase 3
https://www.staging.medscape.com/viewarticle/940709

Nov 9th, 2020 - Patients with active ankylosing spondylitis (AS) experienced rapid clinical response to the oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) in a phase 3, randomized, double-blind, placebo-controlled study. Tofacitinib was significantly mor...

Tofacitinib Effective for Ankylosing Spondylitis in Phase 3
https://www.medscape.com/viewarticle/940709

Nov 9th, 2020 - Patients with active ankylosing spondylitis (AS) experienced rapid clinical response to the oral Janus kinase (JAK) inhibitor tofacitinib (Xeljanz) in a phase 3, randomized, double-blind, placebo-controlled study. Tofacitinib was significantly mor...

Fast Five Quiz: Ankylosing Spondylitis Signs and Symptoms
https://reference.medscape.com/viewarticle/932588_4

Jul 1st, 2020 - The age of onset of AS is usually from the late teens to 40 years. Onset in persons older than 50 years is unusual, although diagnosis of mild or asymptomatic disease may be made at a later age. Insidious onset of low back pain is the most common ...

Fast Five Quiz: Ankylosing Spondylitis Signs and Symptoms
https://reference.medscape.com/viewarticle/932588_1

Jul 1st, 2020 - Ankylosing spondylitis (AS) is a chronic, multisystem inflammatory disorder primarily affecting the axial skeleton and sacroiliac joints. AS is one of the seronegative spondyloarthropathies, which are multisystem inflammatory diseases that affect ...

Fast Five Quiz: Ankylosing Spondylitis Signs and Symptoms
https://reference.medscape.com/viewarticle/932588

Jul 1st, 2020 - Ankylosing spondylitis (AS) is a chronic, multisystem inflammatory disorder primarily affecting the axial skeleton and sacroiliac joints. AS is one of the seronegative spondyloarthropathies, which are multisystem inflammatory diseases that affect ...

see more →

Patient Education  51 results see all →